Abstract: Topical analgesics, generally comprising calendula oil and cornmint oil, and methods of use.

Abstract: This invention relates to an antiviral composition for the treatment of plant viruses comprising an effective amount of Tagetes minuta oil, its active constituents, Z-&bgr;-ocimene and dihydrotagetone, or any mixture thereof. The invention also relates to the use of Tagetes minuta oil, its active constituents Z-&bgr;-ocimene and dihydrotagetone, or any mixture thereof for the treatment of plant viruses.

Abstract: The present invention provides novel compositions comprising a Nigella sativa L. sterol fraction. The present invention also provides novel compositions comprising ∃-sitosterol, campesterol, ∃-amyrin, stigmasterol, or any combination thereof. The present invention provides novel methods for treating and preventing fungal infections, bacterial infections, and vaginal diseases and disorders by administering the novel compositions of the invention. The present invention also provides methods for treating or preventing inflammation, pain and/or allergic reactions by administering the novel compositions of the invention.

Abstract: Pharmaceutical compositions comprising a macromolecular pharmaceutical agent in mixed micellar form are disclosed. The mixed micelles are formed from an alkali metal alkyl sulfate, and at least three different micelle-forming compounds as described in the specification. Micelle size ranges between about 1 and 10 nanometers. Methods for making and using the compositions are also disclosed. A preferred method for administering the present composition is through the buccal region of the mouth.

Abstract: The invention features methods of reducing the level of a &bgr;-amyloid (A&bgr;) polypeptide using an Cimicifuga extract. The invention also features methods of producing an active fraction from an extract of Cimicifuga. The invention further features a composition containing an active fraction of a Cimicifuga extract and an article of manufacture containing such a composition.

Abstract: A dietary supplement comprising as its active ingredients soybean, mushroom and mung bean is used in a method to in a method to ameliorate at least one effective malignancy or viral infection or to enhance immune functions. The active components of the dietary supplement include phytoestrogens, &bgr;-glucans, saponins, inositol hexaphosphate, and lectins.

Abstract: Compositions based on Heliopsis longipes root used orally in treating xerostomia, for dry mouth, increasing salivation, alleviating dry mouth, and in maintaining or improving oral hygiene; as local contact anesthetics; as a cough suppressant, and as an oral sensate-producing desirable sensations in the oropharynx. The herbal composition includes an extract from Heliopsis longipes root and an oral carrier for the extract. A suitable amount of extract is from about 0.01 to about 10 weight percent of the overall composition. A variety of compositions include an oral carrier; preferred compositions are: 1) a gum with a solid exterior and a liquid center, both the exterior and center containing an effective amount of the extract composition; 2) a solid gum, 3) lozenges; candies, confections and 4) flavored liquid sprays and drops, and mouthwashes. The invention is further useful as an enhancer and potentiator of flavor.

Abstract: The present invention is directed toward a method for inhibiting COX-2 in an organism. In particular, the method is preferably directed toward selectively inhibiting COX-2 in an organism. The method comprises administering to the organism an organic extract isolated from a non-edible plant wherein such extract inhibits COX-2. A method to purify a composition that exhibits COX-2 inhibition and COX-2 selective inhibition from the organic extract is also provided. In addition, a method for treating and/or preventing COX-2 mediated inflammation or inflammation-associated disorders in an organism is provided.

Abstract: Compositions comprising zinc, magnesium and vitamin B6 and optionally theanine are effective for enhancing muscle and tissue recovery during sleep, following intense physical exercise.

Abstract: The invention concerns the use in a cosmetic composition or for preparing a pharmaceutical composition of at least a plant extract of the genus Chrysanthemum for stimulating skin and/or hair pigmentation. The invention also concerns a composition containing at least one active principle and an extract of at least a plant of the genus Chrysanthemum.

Abstract: This invention relates to an antiviral composition for the treatment of plant viruses comprising an effective amount of Tagetes minuta oil, its active constituents, Z-&bgr;-ocimene and dihydrotagetone, or any mixture thereof. The invention also relates to the use of Tagetes minuta oil, its active constituents Z-&bgr;-ocimene and dihydrotagetone, or any mixture thereof for the treatment of plant viruses.

Abstract: A Chinese herb medicine composition for a cancer prophylaxis and therapy includes Honeysuckle Flower, Mother Chrysanthemum Flower, Dandelion Herb, Viola Yedoensis and Semiaquilegia adosoides (DC) makino. The Chinese herb medicine composition is composed with a special ratio, and the special ratio of Honeysuckle Flower: Mother Chrysanthemum Flower: Dandelion Herb: Viola Yedoensis: Semiaquilegia adosoides (DC.) makino by weight is 1:1:1:1:1.

Abstract: A method including administering a beverage composition suitable for human consumption including effective amounts of the following solubilized components, a calcium compound, an organic acid in an amount up to the equivalent amount of a calcium of the calcium compound, an isoflavone, and inulin wherein the effective amounts are sufficient to reduce the risk of bone density loss and are solubilized by a stabilizing agent including one or more of maltol, carrageenan and maltodextrin, and xanthan gum.

Abstract: The present invention relates to a preparation for stimulating or enhancing an immune system comprising one or more agents that stimulate T-lymphocytes in vivo. Such a preparation can be sued in the prophylaxis and/or treatment of a medical condition. The invention further relates to a preparation for use in a pharmaceutical or food product and to a preparation for medical use.

Abstract: The invention provides methods that increase retrievable fluid from a breast duct of a patient. Later a portion of the increased fluid reservoir can be collected for analysis, or analyzed in situ. Ductal fluid typically contains ductal epithelial cells and other markers that can aid in identifying a breast condition, including breast cancer and precancer.

Abstract: A mixed substance for treating hypertension, constipation, detoxification, boost immune system produced by extracting arctium lappa L., carrot, and whole radish with water one or two hours at temperature 70° C. 100° C. under agitating, separated the extracts and solid by-products, vacuum condensed the extracts, then at low temperature lyophilized condensed extracts to powder, encapsulated powder or pressed powder to tablet. Patient taking a daily dosage of this vegetable medicine have shown greatly improved healthy condition.

Abstract: An oral micro-emulsion composition comprising a Carduus marianus extract, silybin or a silybin derivative; an organic solvent; a surfactant; and an oil provides a high in vivo bioavailability of silybin.

Abstract: The invention refers to the herbal composition which consists of: the plant of centaury (Centauri herba) 12.3% by wt., the root of dandelion (Teraxaci radix) 9.7% by wt., the fruit of juniper (Juniperi communis fructus) 6.2% by wt., the plant of nettle (Urticae herba) 7.4% by wt., the root of nettle (Urticae radix) 7.0% by wt., the root of chicory (Cichorii radix) 17.7% by wt., the leaf of black mulberry (Morus nigra folium) 7.4% by wt., the flower of yarrow (Achilleae millefolii flos) 3.5% by wt., the leaf of bilberry (Vaccinii myrtilli folium) 6.6% by wt., the pod of beans (Phaseoli fructus sine semeni) 14.4% by wt., and the root of valerian (Valerianae officinalis radix) 7.8% by wt., and to the medicament against diabetes mellitus type II obtained from it. The medicament is anticipated to be administered perorally in form of tea, a tincture and a pill.

Abstract: Provided herein are medicinal compositions of matter that comprise an anti-hepatitis medication component and a component which contains compounds found in the extract of the milk thistle plant, Silybum marianum. Through use of the compositions of the invention a heretofore unobserved synergy is observed in the treatment of chronic infectious hepatitis in which the liver of a patient treated with a composition according to the invention is protected from degradation, which in many cases may prolong the life of the patient and aid in the patient's recovery from hepatitis by strengthening liver functions. The invention also provides procedures for administering the composition to patients afflicted with hepatitis.

Abstract: Compositions for treating hepatic disorders via oral or parenteral administration include Salvia miltiorrhiza and Polyporus umbellatus in proportions of about 1:1 to about 5:1, and may comprise from about 6% to about 30% of the total weight of the composition which may also include other herbs such as Curcuma longa, Astragalus membranaceus, Loranthus parasiticus and Polygonum cuspidatum.

Abstract: Rapid, convenient and inexpensive methods for preparing fungicidal suspensions from Inula are described. Methods for controlling fungal disease and crops by using alkaline solutions are also disclosed.

Abstract: This invention relates to a method of treating and preventing inflammatory disorders and related conditions using an extract of feverfew. Particularly, the invention includes a method of treating and preventing inflammatory disorders and related conditions which comprises applying a topical composition comprising an effective amount of an extract of feverfew to a patient and a method of treating and preventing inflammatory disorders and related conditions of the skin by applying a topical composition containing an effective amount of an extract of feverfew to a patient. In addition, the invention includes a method of treating and preventing inflammatory disorders and related conditions by applying a topical composition containing an effective amount of an extract of feverfew to a patient where said extract is substantially free of &agr;-unsaturated &ggr;-lactone.

Abstract: An object of the present invention is to provide a very effective health food exhibiting the effect near that which has been already achieved by the traditional Chinese medical science. The present invention relates to a health food product comprising cholic acid, especially to a health food product comprising cholic acid and isoflavone and/or isoflavone glycoside.

Abstract: The present invention provides novel adjuvants which comprise oil bodies. The invention also provides vaccine formulations comprising oil bodies and an antigen and methods for preparing the vaccines and the use of the vaccines to elicit an immune response.

Abstract: The invention provides a composition and a method for lowering blood serum cholesterol levels or for preventing elevated blood serum cholesterol levels, as well as suitable composition comprising (a) one or more phytosterols and/or phytostanols or a mixture thereof capable of reducing cholesterol absorption in the intestine, (b) a composition capable of inhibiting cholesterol biosynthesis, and (c) a composition capable of increasing cholesterol metabolism, wherein at least one of compositions b. and c. is preferably derived from plants.

Abstract: A novel composition for treating nervous system disorders. The composition is formed by preparing a mixture comprising an effective amount of vitamin B-6, folic acid, vitamin C, magnesium, vitamin B-3, copper, probiotics, fructo-oligosaccharide (FOS), betaine, pancreatin, papain, pepsin, vitamin B-1, vitamin B-2, vitamin B-12, biotin, pantothenic acid, chromium polynicotinate and a digestive support ingredient selected from the group consisting of dandelion root, juniper, aloe vera, burdock, ginger root, artichoke, and kelp. Other ingredients may include: beta carotene, vitamin E, selenium, zinc, sea vegetation, alfalfa, trace minerals and molybdenum.

Abstract: A compound and method of using such compound is disclosed that, when administered to an animal, is capable of arresting the inflammatory response in affected tissues and facilitates the repair and maintenance of damaged tissues in the joints of vertebrates. The combination of natural physiological metabolites and herbal phytochemicals is used to treat connective tissue diseases, the composition preferably orally administered. One embodiment of the composition includes chondroitin sulfate and glucosamine that, when ingested by a vertebrate, suppresses the degradation of connective tissue by an autoimmune response. A preferred composition of the present invention includes a palatability agent, an herbal phytochemical, and a metabolic precursor that synergistically acts to increase blood circulation, thereby enhancing transport of the phytochemical and metabolic precursors to an affected site whereby deleterious inflammatory byproducts are removed.

Abstract: The present invention relates to an Extract of Echinops spinosus L (Asteraceae) and organic solvent soluble fractions of the extract that may be used in the treatment of cancer.

Abstract: A pharmaceutical composition for the treatment and/or prophylaxis of diseases caused by type I hypersensitivity reactions consisting essentially of Glicophosphopeptical, or pure Nigella Sativa seeds, in a concentration which stimulate Th1 lymphocytes and selectively switch-off the eosinophilic airway inflammation

Abstract: The present invention relates to a food supplement, either in the form of a snack bar or a beverage, which contains cartilage supplements. The cartilage supplements include chondroitin sulfate, glucosamine sulfate, and hyaluronic acid. The food supplement may additionally be fortified with cetyl myristoleate.

Abstract: This invention relates to the use of parthenolide or derivative thereof and chrysanthemum ethanolic extract containing parthenolide in the treatment and prevention of cancer, including cancer associated with an increased COX-2 expression and increased constitutive activation of NF-&kgr;B.

Abstract: Multipurpose skin preparations in the form of oil-in-water emulsions are disclosed. The skin preparations are prepared by combining an oil phase and an aqueous phase. The oil phase comprises a siloxane polymer, a cyclic silicone, an anti-oxidant, and an emollient. In a second version of the present invention, the oil phase includes a copolymer comprising PPG-12/SMDI. The aqueous phase comprises at least a humectant, a rheology modifier, a thickener, and water. The inventive preparations are useful in topical application to the skin, are highly water resistant, remain on the skin after multiple washings, form a protective barrier on the skin, and effectively deliver and maintain moisturizing and therapeutic agents on the skin. It is believed that the skin preparations of the present invention also effectively deliver and maintain moisturizing and select therapeutic agents, biological agents, pharmaceutical agents, and the like, which are useful for the treatment of pathologies of the skin.

Abstract: The present invention provides pharmaceutical compositions which include Chinese herbs. These pharmaceutical compositions are especially effective in treating patients with immunological disorders, such as asthma, atopic eczema, atopic dermatitis, allergic rhinitis and rheumatoid arthritis. The pharmaceutical compositions contain ophiopogon (Tuber Ophiopogonis), pinellia (Tuber Pinelliae), raw licorice (Radix Glycyrrhizae), tang-shen (Radix Codonopsitis) or American ginseng (Radix Pancis Quinquefolii), and lantern tridax (Herba Tridacis procumbentis)/Taiwan adenostema (Herba Adenostematis)/heartleaf houttuynia (Herba houttuyniae). So far, Taiwan adenostema, and heartleaf houttuynia have been found only in Taiwan. Lantern tridax has been found in Taiwan and South America.

Abstract: The invention provides a novel herbal formulation useful for the treatment of skin disorders and comprising two or more plant extracts selected from Tagetes erecta, Moringa oleifera, Ocimum sanctum, Tridax procumbens, Aloe vera, and Gum olibanum together with conventional additives.

Abstract: The present invention provides compositions and methods of administering nutritional supplements. The compositions and methods of the present invention are based on nutritional supplements that are encapsulated in lipid vesicles for administration as an aerosol or liquid droplet spray.

Abstract: The present invention provides a hair oil comprising a blend of:

Abstract: Compositions and methods for treating hand or wrist discomfort are provided. The compositions comprise singly or in combination herbals, natural nutritional supplements, minerals and vitamins. Methods of making these compositions are also provided.

Abstract: Emollient compositions for topical administration consisting of hydrophilic:hydrophobic emulsions containing a polyacrylate carrier, a vehicle, a mixture of C16:0, C18:0, C18:1 fatty acids and derivatives as penetrants, a balanced mixture of unsaturated C18:2, C18:2 and C18:3 fatty acids, a natural anti-inflammatory compound, a natural analgesic compound, a natural estrogenic compound and a fragrance; Methods of their use for ameliorating symptoms of disease including mammary fibrocystic disease, cyclic mastitis, inflammation and general and specific pre- and post-menopausal pain and swelling.

Abstract: Disclosed herein are novel compositions and/or formulations containing minoxidil as an active ingredient in combination with other active agents and/or enhancer agents (e.g., saw palmetto extract and nettle root extract) which increase the hair growth capability of the composition. Also disclosed are methods of using the novel compositions to treat male patterned baldness and to stimulate hair growth on the scalp, including both the apex and frontal regions of the scalp.

Abstract: A pharmaceutical composition solubilized in a propellant that can be administered buccally or to the lungs using a metered dose dispenser is provided. The composition comprises a pharmaceutical agent; glycerin and/or polyglycerin; phenol and/or methyl phenol; and at least one absorption enhancing compound. A pressurized container with the composition and a methods of making the composition are also provided.

Abstract: Compositions and methods for treating back or leg discomfort are provided. The compositions comprise singly or in combination herbals, natural nutritional supplements, minerals and vitamins. Methods of making these compositions are also provided.

Abstract: A novel composition for treating nervous system disorders. The composition is formed by preparing a mixture comprising an effective amount of vitamin B-6, folic acid, vitamin C, magnesium, vitamin B-3, copper, probiotics, fructo-oligosaccharide (FOS), betaine, pancreatin, papain, pepsin, vitamin B-1, vitamin B-2, vitamin B-12, biotin, pantothenic acid, chromium polynicotinate and a digestive support ingredient selected from the group consisting of dandelion root, juniper, aloe vera, burdock, ginger root, artichoke, and kelp. Other ingredients may include: beta carotene, vitamin E, selenium, zinc, sea vegetation, alfalfa, trace minerals and molybdenum.

Abstract: Compositions comprising lycopene, Serenoa repens, Pygeum africanum, and Urtica dioica are provided. The compositions are preferably formulated with an alcohol extract of the dried, cut plant parts. Methods of using such compositions for treating various conditions and diseases, including benign prostatic hypertrophy and prostate cancer are also provided.

Abstract: Compositions comprising lycopene, Serenoa repens, Pygeum africanum, and Urtica dioica are provided. The compositions are preferably formulated with an alcohol extract of the dried, cut plant parts. Methods of using such compositions for treating various conditions and diseases, including benign prostatic hypertrophy and prostate cancer are also provided.

Abstract: Rapid, convenient and inexpensive methods for preparing fungicidal suspensions from Inula are described. Methods for controlling fungal disease and crops by using alkaline solutions are also disclosed.

Abstract: An improved medicinal composition includes an effective amount of a pain relieving and anti-inflammatory pharmaceutical and an effective amount of a nutraceutical in a pharmaceutically acceptable base. At least one of the pharmaceutical and the nutraceutical treats a condition caused by an immune response to a virus, a microorganism, or an atmospheric pollutant or allergen. The pain relieving and anti-inflammatory pharmaceutical is preferably acetaminophen or a non-steroidal anti-inflammatory drug (NSAID). The medicinal composition may additionally include a pharmaceutical decongestant or antihistamine. The nutraceutical is preferably an immune booster, an anti-oxidant, a liver protectant, or a combination thereof. Methods of using these compositions to treat conditions caused by an immune response are also disclosed.

Abstract: A medicinal composition for treating acid reflux disease comprises an effective amount of a pharmaceutical and an effective amount of a nutraceutical in a pharmaceutically acceptable base. The pharmaceutical is an acid-controlling pharmaceutical, such as cimetidine or ranitidine. The nutraceutical is a nutraceutical which is useful for treating stomach disorders, a nutraceutical which protects the mucosal linings of the digestive system, or a liver protectants. A method of using such a cmposition in the treatment of acid reflex disease is also disclosed.

Abstract: A pressurized container with an aerosol pharmaceutical formulation, and a process for making the formulation, are provided. The formulation comprises a pharmaceutical agent, a phenol, glycerin or polyglycerin, and an additional ingredient such as an alkali metal alkyl sulfate, polidocanol alkyl ether or the like. The formulation is placed in the pressurized container, which is then charged with a propellant. A method of treating a medical condition, by spraying the formulation into the mouth or lungs, is also provided.

Abstract: A first pharmacologically active substance contained in a pharmaceutical, which acts on a specific biological function, is released according to a predetermined release profile (D.1), FIG. 1, and generates a first activity profile (1.1) that has flank phases with increasing and decreasing activity intensity. For changing such flank phases, an additional pharmacologically active substance is used which acts on the same biological function and which is released according to a release profile (D.2) such that its activity profile (I.2) overlays the first activity profile (I.1) within the flank phase to be changed. For shortening an end flank phase, an additional substance is used whose activity is counter to the activity of the first substance and cancels, reduces, or overpowers this activity in its declining phase. Accordingly, with the aforementioned pharmaceutical, undesirable aftereffects of a pharmacologically active substance, for example, can be prevented.

Abstract: A mixed micellar aerosol pharmaceutical formulation is provided. The formulation comprises a pharmaceutical agent, an alkali metal alkyl sulphate, at least three micelle-forming compounds, a phenol and a propellant. The propellant provides enchanced absorption of the pharmaceutical agent in the buccal region. A process of making and a method of administering the composition are also included.